Liang, Linda A.
Zeissig, Sylke R.
Schauberger, Gunther
Merzweiler, Sophie
Radde, Kathrin
Fischbeck, Sabine
Ikenberg, Hans
Blettner, Maria
Klug, Stefanie J.
Funding for this research was provided by:
Deutsche Krebshilfe (105827, 106619, 107247, 108047, and 107159)
Technische Universität München
Article History
Received: 14 February 2022
Accepted: 20 June 2022
First Online: 9 July 2022
Declarations
:
: Informed consent to participate in the MARZY prospective cohort study was provided in written form by all study participants prior to screening at study baseline. The MARZY study was approved by the ethical committee of the state of Rhineland-Palatinate (Landesärztekammer Rheinland-Pfalz: 837.438.03 (4100)) and the state government data protection office. All recruitment, data collection and analyses were performed in accordance to Good Epidemiological Practice guidelines and the Declaration of Helsinki.
: Not Applicable (NA).
: HI reports co-ownership of a laboratory for cytology and molecular diagnostics. All other authors declare no competing interests.